en

PRODUCT DETAIL

DOCETAXEL KABI 160 mg/8 ml infúzny koncentrát

Code 1564A
MA number EU/1/12/770/003
Product Form: con inf 1x8 ml/160 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CD Taxanes
L01CD02 Docetaxel
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 22.05.2012
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 29.10.2021
eu-flag.png sk-flag.png